ReviewDrug, healthcare and patient safety2015

Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.

Alberto Gajofatto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.